Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Avidity Biosciences, Inc. (RNA) had Weighted-Average Shares Outstanding (Basic) of 111.58M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$10.90M |
|
$-322.30M |
|
-- |
|
$10.90M |
|
$389.83M |
|
$-378.94M |
|
$56.63M |
|
$-322.30M |
|
$-322.30M |
|
$-322.30M |
|
$-322.30M |
|
$-322.30M |
|
$-322.30M |
|
$-378.94M |
|
$-397.61M |
|
|
Weighted-Average Shares Outstanding (Basic) |
111.58M |
111.58M |
|
$-2.89 |
|
$-2.89 |
|
| Balance Sheet Financials | |
$1.54B |
|
$12.67M |
|
$21.61M |
|
$1.56B |
|
$98.02M |
|
-- |
|
$40.92M |
|
$138.94M |
|
$1.42B |
|
$1.42B |
|
$1.42B |
|
119.89M |
|
| Cash Flow Statement Financials | |
$-300.87M |
|
$-854.20M |
|
$1.19B |
|
$185.38M |
|
$222.66M |
|
$37.29M |
|
$51.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3477.43% |
|
-3477.43% |
|
-3648.77% |
|
-2957.71% |
|
-2957.71% |
|
$-307.94M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-22.62% |
|
-22.62% |
|
-20.61% |
|
-22.62% |
|
$11.89 |
|
$-2.76 |
|
$-2.70 |
|